STIPE THERAPEUTICS
Live / Registered — Registered (as of 02 Apr 2024)
What this means for you
Registered since 02 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79363664
- Registration number
- 7341867
- Mark type
- Stylized text
- Filed
- 29 Jun 2022
- Published for opposition
- 16 Jan 2024
- Registered
- 02 Apr 2024
- Attorney of record
- Shoko Naruo
Goods and services
- Class 001 — Chemicals: Chemicals for use in industry and science; chemicals for use in manufacture of peptides, small molecules, and a wide variety of goods; biological preparations for use in industry and science; biological preparations for use in manufacture; chemicals and chemical preparations for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in the pharmaceutical industry, namely, active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, tumorigenesis, autoimmune disorders, and other inflammatory diseases; chemicals and chemical preparations for use in biotechnological manufacturing processes; chemical and chemical preparations for use in biotechnological product development; chemicals and chemical preparations for use in the biotechnological industry; reagents for scientific purposes; reagents for medical research; enzymes for scientific purposes; enzymes for use in the manufacture of pharmaceuticals; biological preparations other than for medical use; proteins for use in industry and science; proteins for use in manufacture; peptides for use in industry and science; peptides for use in manufacture of pharmaceuticals
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention of cancer, tumorigenesis, autoimmune disorders, and other inflammatory diseases, medical preparations for the treatment of cancer, tumorigenesis, autoimmune disorders, and other inflammatory diseases, and veterinary pharmaceutical preparations for the treatment of cancer, tumorigenesis, autoimmune disorders, and other inflammatory diseases; medical preparations, namely, adjuvants used in vaccines; sanitary preparations for medical purposes; dietetic food and preparations adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; pharmaceuticals for the treatment of cancer and autoimmune disorders; drug delivery agents in the form of intravenous administration fluids that facilitate the delivery of pharmaceutical preparations; synthetic proteins and peptides for pharmaceutical and medical purposes, namely, for the treatment of cancer, tumorigenesis, autoimmune disorders, and other inflammatory diseases; regulatory proteins and peptides for pharmaceutical and medical use, namely, protein arrays for treating cancer, tumorigenesis, autoimmune disorders, and other inflammatory diseases
- Class 042 — Scientific and technological services: Design and development of computer hardware and software; clinical research in the field of cancer, tumorigenesis, autoimmune disorders, and other inflammatory diseases; medical and scientific research, namely, conducting clinical trials for others; drug discovery services; development of pharmaceutical preparations and medicines; research relating to medicines; medical and pharmacological research services; medical laboratories; scientific and technological services, namely, research and design in the field of medical technology; product design and development of medical apparatus; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information relating to medical and veterinary research and development
Owner
Prosecution history
- 09 Nov 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 18 Oct 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 18 Oct 2024 — FINAL DISPOSITION PROCESSED
- 03 Jul 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 02 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jan 2024 — PUBLISHED FOR OPPOSITION
- 13 Jan 2024 — NOTIFICATION PROCESSED BY IB
- 27 Dec 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 27 Dec 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 27 Dec 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Dec 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE